Since 1980, AGEs have been linked directly to both diabetic complications and aging itself (hence the acronym). AGEs accumulate in the lens, cornea, and retina of the eye, where they appear to cause the browning and opacity of the lens characteristic of senile cataracts. AGEs accumulate in the membranes of the kidney, in nerve endings, and in the lining of arteries, all tissues typically damaged in diabetic complications. Because AGE accumulation appears to be a naturally occurring process, although it is exacerbated and accelerated by high blood sugar, we have evolved sophisticated defense mechanisms to recognize, capture, and dispose of AGEs. But AGEs still manage to accumulate in tissues with the passing years, and especially so in diabetics, in whom AGE accumulation correlates with the severity of complications.
One protein that seems particularly susceptible to glycation and cross-linking is collagen, which is a fundamental component of bones, cartilage, tendons, and skin. The collagen version of an AGE accumulates in the skin with age and, again, does so excessively in diabetics. This is why the skin of young diabetics will appear prematurely old, and why, as the Case Western University pathologist Robert Kohn first suggested, diabetes can be thought of as a form of accelerated aging, a notion that is slowly gaining acceptance. It’s the accumulation and cross-linking of this collagen version of AGEs that causes the loss of elasticity in the skin with age, as well as in joints, arteries, and the heart and lungs.
The process can be compared to the toughening of leather. Both the meat and hide of an old animal are tougher and stiffer than those of a young animal, because of the AGE-related cross-linking that occurs inevitably with age. As Cerami explains, the aorta, the main artery running out of the heart, is an example of this stiffening effect of accumulated and cross-linked AGEs. “If you remove the aorta from someone who died young,” says Cerami, “you can blow it up like a balloon. It just expands. Let the air out, it goes back down. If you do that to the aorta from an old person, it’s like trying to inflate a pipe. It can’t be expanded. If you keep adding more pressure, it will just burst. That is part of the problem with diabetes, and aging in general. You end up with stiff tissue: stiffness of hearts, lungs, lenses, joints…. That’s all caused by sugars reacting with proteins.”
AGEs and the glycation process also appear to play at least one critical role
That glycation and AGEs are critical factors in diabetic complications and in heart disease has recently been demonstrated by experiments with compounds known as
When biochemists discuss oxidative stress, glycation, and the formation of advanced glycation end-products, they often compare what’s happening to a fire simmering away in our circulation. The longer the fire burns and the hotter the flame, the more damage is done. Blood sugar is the fuel. “Current evidence points to glucose not only as the body’s main short-term energy source,” as the American Diabetes Association recently put it, “but also as the long-term fuel of diabetes complications.”
But there is no reason to believe that glucose-induced damage is limited only to diabetics, or to those with metabolic syndrome, in whom blood sugar is also chronically elevated. Glycation and oxidation accompany every fundamental process of cellular metabolism. They proceed continuously in all of us. Anything that raises blood sugar—in particular, the consumption of refined and easily digestible carbohydrates—will increase the generation of oxidants and free radicals; it will increase the rate of oxidative stress and glycation, and the formation and accumulation of advanced glycation end-products. This means that anything that raises blood sugar, by the logic of the carbohydrate hypothesis, will lead to more atherosclerosis and heart disease, more vascular disorders, and an accelerated pace of physical degeneration, even in those of us who never become diabetic.
SUGAR
M. Delacroix, a writer as charming as he is prolific, complained once to me at Versailles about the price of sugar, which at that time cost more than five francs a pound. “Ah,” he said in a wistful, tender voice, “if it can ever again be bought for thirty cents, I’ll never more touch water unless it’s sweetened!” His wish was granted….
JEAN ANTHELME BRILLAT-SAVARIN,
WHEN BIOCHEMISTS TALK ABOUT “SUGAR,” they’re referring to a whole host of very simple carbohydrate molecules, all of which are characterized, among other things, by their sweet taste and ability to dissolve in water. Their chemical names all end in “-ose”—glucose, fructose, and lactose, among others. When physicians talk about blood sugar, they’re typically talking about glucose, although other sugars can be found in the bloodstream at very much lower concentrations. Then there’s the common usage of “sugar,” meaning the sweet, powdered variety that we put in our coffee or tea. This is sucrose, which in turn is constituted of equal parts glucose and fructose. In the discussion to come, when we refer to “sugar” we’ll always be talking about sucrose. When we use the term “blood sugar,” we’ll be talking about glucose.
When nutritionists in the 1960s discussed the pros and cons of sugar and starches, their concern was whether
In the mid-1970s, Gerald Reaven initiated the study of glycemic index to test what he called the “traditionally held tenet” that simple carbohydrates are easier to digest than more complex carbohydrates “and that they therefore produce a greater and faster rise” in blood sugar and insulin after a meal. Reaven’s experiments confirmed this proposition, but he was less interested in blood sugar than in insulin, and so left this research behind. It was taken up a few years later by David Jenkins and his student Thomas Wolever, both of whom were then at Oxford University. Over the course of a year, Wolever and Jenkins tested sixty-two foods and recorded the